[
  {
    "ts": null,
    "headline": "Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?",
    "summary": "Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell?",
    "url": "https://finnhub.io/api/news?id=8455aec0bd8f34dd2264622ad6d1dba084f122eb4863f7839b14233df1c5fa3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741885430,
      "headline": "Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?",
      "id": 133193259,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell?",
      "url": "https://finnhub.io/api/news?id=8455aec0bd8f34dd2264622ad6d1dba084f122eb4863f7839b14233df1c5fa3e"
    }
  },
  {
    "ts": null,
    "headline": "Citi says SMid biotechs alternative to large caps as it starts coverage",
    "summary": "Investing.com -- Citi has expanded its biopharmaceutical research coverage, initiating coverage on seven small- and mid-cap (SMid) biotechnology companies. Citi said SMid biotechs remain an attractive alternative to large-cap pharmaceutical firms, particularly amid healthcare policy uncertainties. Citi initiated coverage with Buy ratings on 89bio (NASDAQ:ETNB), price target $25. Apogee (NASDAQ:APOG), price target $95. Avidity, price target $70, BioNTech (NASDAQ:BNTX), price target $145. Kiniksa,",
    "url": "https://finnhub.io/api/news?id=db3d0f886436223fa4932761e21d94c635c729d4d6a59db103fdf8ec03ca3e3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741880086,
      "headline": "Citi says SMid biotechs alternative to large caps as it starts coverage",
      "id": 133193261,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Investing.com -- Citi has expanded its biopharmaceutical research coverage, initiating coverage on seven small- and mid-cap (SMid) biotechnology companies. Citi said SMid biotechs remain an attractive alternative to large-cap pharmaceutical firms, particularly amid healthcare policy uncertainties. Citi initiated coverage with Buy ratings on 89bio (NASDAQ:ETNB), price target $25. Apogee (NASDAQ:APOG), price target $95. Avidity, price target $70, BioNTech (NASDAQ:BNTX), price target $145. Kiniksa,",
      "url": "https://finnhub.io/api/news?id=db3d0f886436223fa4932761e21d94c635c729d4d6a59db103fdf8ec03ca3e3e"
    }
  },
  {
    "ts": null,
    "headline": "Bridging the Science Gap: A Conversation on Trust and Misinformation at SXSW",
    "summary": "At SXSW, an important conversation took center stage: how can companies, brands and the medical community bridge the growing communication gap between science and the public? In an era of information...",
    "url": "https://finnhub.io/api/news?id=803192a2cb3daf67c1b39ed8ae569e9bc39d157649c95af20606451538ddd303",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741875548,
      "headline": "Bridging the Science Gap: A Conversation on Trust and Misinformation at SXSW",
      "id": 133163508,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "At SXSW, an important conversation took center stage: how can companies, brands and the medical community bridge the growing communication gap between science and the public? In an era of information...",
      "url": "https://finnhub.io/api/news?id=803192a2cb3daf67c1b39ed8ae569e9bc39d157649c95af20606451538ddd303"
    }
  },
  {
    "ts": null,
    "headline": "CDC Nomination Hearing Canceled Minutes Before Start",
    "summary": "CDC Nomination Hearing Canceled Minutes Before Start",
    "url": "https://finnhub.io/api/news?id=74641f978189eb3562a57dafad819aea8f9cb66679aa8512cfb54c919abc6b4f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741861500,
      "headline": "CDC Nomination Hearing Canceled Minutes Before Start",
      "id": 134358688,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "CDC Nomination Hearing Canceled Minutes Before Start",
      "url": "https://finnhub.io/api/news?id=74641f978189eb3562a57dafad819aea8f9cb66679aa8512cfb54c919abc6b4f"
    }
  }
]